GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hansen Medical Inc (NAS:HNSN) » Definitions » PE Ratio

Hansen Medical (Hansen Medical) PE Ratio

: At Loss (As of Today)
View and export this data going back to 2006. Start your Free Trial

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-04-19), Hansen Medical's share price is $3.99. Hansen Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2016 was $-4.55. Therefore, Hansen Medical's PE Ratio for today is At Loss.


The historical rank and industry rank for Hansen Medical's PE Ratio or its related term are showing as below:

HNSN' s PE Ratio Range Over the Past 10 Years
Min: At Loss   Med: At Loss   Max: At Loss
Current: At Loss



HNSN's PE Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 26.735 vs HNSN: At Loss

Hansen Medical's Earnings per Share (Diluted) for the three months ended in Mar. 2016 was $-0.51. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2016 was $-4.55.

As of today (2024-04-19), Hansen Medical's share price is $3.99. Hansen Medical's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2016 was $-4.56. Therefore, Hansen Medical's PE Ratio without NRI for today is At Loss.

Hansen Medical's EPS without NRI for the three months ended in Mar. 2016 was $-0.51. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2016 was $-4.56.

Hansen Medical's EPS (Basic) for the three months ended in Mar. 2016 was $-0.51. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2016 was $-4.55.


Hansen Medical PE Ratio Historical Data

The historical data trend for Hansen Medical's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansen Medical Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
PE Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

Hansen Medical Quarterly Data
Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16
PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Hansen Medical's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hansen Medical PE Ratio Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Hansen Medical's PE Ratio distribution charts can be found below:

* The bar in red indicates where Hansen Medical's PE Ratio falls into.



Hansen Medical PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Hansen Medical's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=3.99/-4.550
=At Loss

Hansen Medical's Share Price of today is $3.99.
Hansen Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.55.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio or PE Ratio (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Hansen Medical  (NAS:HNSN) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Hansen Medical PE Ratio Related Terms

Thank you for viewing the detailed overview of Hansen Medical's PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hansen Medical (Hansen Medical) Business Description

Traded in Other Exchanges
N/A
Address
Hansen Medical Inc, formerly known as AutoCath Inc, was incorporated in Delaware in 2002. The Company completed its initial public offering on February 28, 2014. The Company develops, manufactures and sells medical robotics designed for accurate positioning, manipulation and stable control of catheters and catheter-based technologies. Its products include Sensei Robotic Catheter System, Magellan Robotic System, Artisan catheter, Lynx catheter, Magellan Robotic Catheter, and CoHesion 3D Visualization Module. Sensei Robotic Catheter System, or Sensei system, is designed to allow physicians to navigate flexible catheters with solid stability and control in interventional procedures within the atrial heart chambers. This system enables physicians to direct the movements of a robotic catheter like the Company's Artisan Control Catheter and Artisan Extend Control Catheter, or Artisan catheters, and Lynx Robotic Ablation Catheter, or Lynx catheter, to an anatomical location. The Sensei system is comprised of two modules: a physician control console and a patient-side module that can be connected to procedure tables. The control console can be located inside the Electro-Physiology Laboratory, or EP lab, and close to the patient or outside the EP lab in a separate location shielded from radiation. The Company's Magellan Robotic System is a peripheral vascular interventional platform that, used in combination with the Magellan Robotic Catheters, has the potential to provide endovascular specialists with vessel navigation, catheter stability during the manual delivery and placement of therapeutic devices, reduced procedural radiation exposure and fatigue, and precise robotic control of distal catheter tips. Magellan Robotic System is comprised of two modules: a physician control console and a patient-side robotic arm that can be connected to procedure tables. The Artisan catheter is a disposable catheter and guide catheter assembly that consists of a telescoping set of control catheters that are integrated to provide the desired motion of the tip of a diagnostic or therapeutic catheter that is inserted through the center lumen of the Artisan catheter. This is designed to accurately control the movement of a third party catheter chosen by the physician. CoHesion 3D Visualization Module, or CoHesion Module, is a software interface between Sensei system and the St. Jude Medical EnSite System for EP procedures. It is designed to provide physicians with 3D visualization to augment their ability to move a catheter throughout the atria, as well as increase control over placement of the catheter in specific locations. The Company markets, sells and supports its products in the United States through a direct sales force of regional sales employees, supported by clinical account managers who provide training, clinical support and other services to customers. Outside the United States, in the European Union, it uses a combination of a direct sales for
Executives
William R Rohn director PO BOX 676367, RANCHO SANTA FE CA 92067
Christopher P. Lowe director, officer: Interim CFO 2511 N LOOP 1604,, SUITE 204, SAN ANTONIO TX 78258
Oracle Institutional Partners L P 10 percent owner 200 GREENWICH AVENUE, 3RD FLOOR, GREENWICH CT 06830
Oracle Partners Lp 10 percent owner 200 GREENWICH AVE, 3RD FL, GREENWICH CT 06830
Larry N Feinberg 10 percent owner C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
Oracle Associates Llc 10 percent owner 200 GREENWICH AVENUE, 3RD FLOOR, GREENWICH CT 06830
Stephen L Newman director 13737 NOEL ROAD, SUITE 100, DALLAS TX 75093
Oracle Ten Fund Master, Lp 10 percent owner C/O ORACLE INVESTMENT MANAGEMENT, INC., 200 GREENWICH AVENUE, GREENWICH CT 06830
Jack W. Schuler Living Trust other: Former 10% Owner 100 NORTH FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045
Family Foundation Schuler other: Former 10% Owner 100 N. FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045
Marjorie L. Bowen director 225 6TH STREET, MANHATTAN BEACH CA 90266
Jack W Schuler director, 10 percent owner 100 N. FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045
Peter J Mariani officer: Chief Financial Officer C/O GUIDANT CORP, 111 MONUMENT CIRCLE #2900, INDIANAPOLIS IN 46204-5129
Bruce Barclay director
Russell C Hirsch director 435 TASSO STREET, SUITE 200, PALO ALTO CA 94301